Horizon Pharma Plc (HZNP) Position Raised by Kopp Investment Advisors Llc; Shareholder Sigma Planning Has Raised Jpmorgan Chase & Co (JPM) Holding

February 11, 2018 - By Michael Collier

Sigma Planning Corp increased its stake in Jpmorgan Chase & Co (JPM) by 16.09% based on its latest 2017Q3 regulatory filing with the SEC. Sigma Planning Corp bought 8,220 shares as the company’s stock declined 6.04% while stock markets rallied. The institutional investor held 59,322 shares of the major banks company at the end of 2017Q3, valued at $5.67 million, up from 51,102 at the end of the previous reported quarter. Sigma Planning Corp who had been investing in Jpmorgan Chase & Co for a number of months, seems to be bullish on the $376.87B market cap company. The stock increased 2.00% or $2.16 during the last trading session, reaching $110.04. About 28.19 million shares traded or 86.16% up from the average. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since February 11, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Kopp Investment Advisors Llc increased its stake in Horizon Pharma Plc (HZNP) by 403.79% based on its latest 2017Q3 regulatory filing with the SEC. Kopp Investment Advisors Llc bought 89,380 shares as the company’s stock declined 38.11% while stock markets rallied. The institutional investor held 111,515 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.41 million, up from 22,135 at the end of the previous reported quarter. Kopp Investment Advisors Llc who had been investing in Horizon Pharma Plc for a number of months, seems to be bullish on the $2.26B market cap company. The stock increased 1.85% or $0.25 during the last trading session, reaching $13.76. About 2.11 million shares traded or 11.03% up from the average. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has declined 28.13% since February 11, 2017 and is downtrending. It has underperformed by 44.83% the S&P500.

Sigma Planning Corp, which manages about $1.21B US Long portfolio, decreased its stake in Cisco Sys Inc (NASDAQ:CSCO) by 28,862 shares to 88,808 shares, valued at $2.99 million in 2017Q3, according to the filing. It also reduced its holding in Ishares Tr (IYK) by 7,816 shares in the quarter, leaving it with 2,401 shares, and cut its stake in Fidelity (FIDU).

Investors sentiment decreased to 0.91 in 2017 Q3. Its down 0.28, from 1.19 in 2017Q2. It fall, as 65 investors sold JPM shares while 767 reduced holdings. 125 funds opened positions while 635 raised stakes. 2.50 billion shares or 7.05% less from 2.69 billion shares in 2017Q2 were reported. Sather Finance Group reported 0.26% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Cls Invs Ltd Liability stated it has 717 shares or 0% of all its holdings. Mcmillion Mgmt Inc stated it has 42,170 shares or 2.65% of all its holdings. Veritas Inv (Uk) Limited owns 2,300 shares for 0.08% of their portfolio. Oakworth Capital owns 103,150 shares for 2.41% of their portfolio. Cortland Advisers Limited Liability stated it has 6.01% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Horan Advsrs Ltd Limited Liability Company holds 2.7% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 46,025 shares. Jones Fincl Companies Lllp owns 63,735 shares or 0.02% of their US portfolio. 57,367 were reported by Wasatch Advsrs Incorporated. Dearborn Partners Ltd owns 0.54% invested in JPMorgan Chase & Co. (NYSE:JPM) for 77,115 shares. Rodgers Brothers Incorporated invested in 6,023 shares or 0.2% of the stock. Smithfield holds 0.39% or 30,252 shares in its portfolio. Summit Asset Mngmt Ltd Llc accumulated 2,275 shares. 3.03 million were accumulated by United Automobile Association. Neville Rodie & Shaw has 132,143 shares for 1.41% of their portfolio.

Among 33 analysts covering JPMorgan Chase & Co (NYSE:JPM), 17 have Buy rating, 2 Sell and 14 Hold. Therefore 52% are positive. JPMorgan Chase & Co had 109 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was downgraded by Goldman Sachs to “Neutral” on Monday, January 11. Citigroup maintained JPMorgan Chase & Co. (NYSE:JPM) rating on Friday, October 6. Citigroup has “Neutral” rating and $96 target. On Friday, July 14 the stock rating was maintained by Oppenheimer with “Hold”. Vetr downgraded the stock to “Strong-Buy” rating in Friday, August 28 report. The firm has “Buy” rating by Argus Research given on Monday, January 18. The firm earned “Outperform” rating on Monday, August 17 by KBW. The firm has “Market Perform” rating given on Tuesday, August 16 by Bernstein. The firm earned “Underperform” rating on Monday, February 22 by Portales Partners. The firm earned “Hold” rating on Wednesday, October 11 by Keefe Bruyette & Woods. Jefferies maintained the stock with “Buy” rating in Tuesday, June 6 report.

Since August 21, 2017, it had 1 buying transaction, and 10 sales for $23.24 million activity. Shares for $5.43M were sold by Petno Douglas B on Saturday, January 13. Shares for $1.99M were sold by Friedman Stacey. Another trade for 16,434 shares valued at $1.84M was sold by BACON ASHLEY. On Saturday, January 13 Erdoes Mary E. sold $7.31 million worth of JPMorgan Chase & Co. (NYSE:JPM) or 65,101 shares. On Saturday, January 13 the insider Giles Nicole sold $425,399. CROWN JAMES S also bought $825,327 worth of JPMorgan Chase & Co. (NYSE:JPM) shares.

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Horizon Pharma had 55 analyst reports since September 9, 2015 according to SRatingsIntel. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) has “Buy” rating given on Monday, November 23 by Jefferies. JMP Securities maintained the shares of HZNP in report on Wednesday, September 27 with “Buy” rating. Mizuho maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) on Monday, August 28 with “Hold” rating. The firm has “Buy” rating by Piper Jaffray given on Monday, August 7. The stock has “Buy” rating by Mizuho on Tuesday, May 10. The firm earned “Buy” rating on Tuesday, August 8 by Jefferies. The rating was maintained by Mizuho with “Buy” on Monday, December 14. The rating was reinitiated by Citigroup on Wednesday, January 6 with “Neutral”. Jefferies maintained the shares of HZNP in report on Friday, October 13 with “Buy” rating. Cantor Fitzgerald maintained the shares of HZNP in report on Thursday, August 17 with “Buy” rating.

Kopp Investment Advisors Llc, which manages about $252.21 million and $109.12M US Long portfolio, decreased its stake in Intersect Ent Inc. (NASDAQ:XENT) by 77,591 shares to 224,372 shares, valued at $6.99 million in 2017Q3, according to the filing.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>